TCL Archive Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations March 28, 2014
TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients December 28, 2012
TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ October 24, 1997
